MXCT — MaxCyte Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates MXCT Bearish with a Setup Score of 23, net conviction 33, actionability 16. How the Setup Score works →

Total Setup Score23
Directional BiasBearish
Net Conviction33
Actionability16 (in range)

Key signals behind this score

About MaxCyte Inc

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for … Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$1.16
Market Cap$118M
Float97.7M
Shares Outstanding107.1M
Price/Sales (TTM)3.65
vs. Analyst Target+254.1% to analyst PT
Profit Margin-121.16%
Operating Margin (TTM)-64.09%
Revenue (TTM)$32.3M
Dividend RateNone
Analyst Target Price$4.11 (6 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $26.2M -$11.8M $23.4M -$9.9M
2021 $33.9M -$19.1M $30.2M -$16.6M
2022 $44.3M -$23.6M $39.2M -$24.7M
2023 $41.3M -$37.9M $36.5M -$44.1M
2024 $38.6M -$41.1M $31.5M -$46.4M
2025 $33.0M -$44.6M $26.8M -$40.1M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $8.5M -$12.4M
Sep 2025 $6.8M -$12.4M
Dec 2025 $7.3M -$9.6M
Mar 2026 $9.7M -$4.8M

Ownership & Float

Insider Ownership1.4%
Institutional Ownership68.0%
Short Float4.6%

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$1.01Near-term / short-term trend
Weekly40-Week SMA$1.19Medium-term trend
Weekly80-Week SMA$2.02Cyclical trend (business cycle)
Weekly200-Week SMA$3.56Secular trend (multi-year)
Monthly10-Month SMA$1.21Near-term monthly trend
Monthly20-Month SMA$2.06Medium-term monthly trend
Monthly40-Month SMA$3.15Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$0.90 support 1.18x 0 months ago
$2.00 resistance 1.58x 9 months ago
$2.80 resistance 2.09x 12 months ago
$3.30 resistance 1.43x 14 months ago

Historical Earnings Reactions (20 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -1.36% -0.79% 45.00% 10.28% -16.67%
1 Day -1.38% -0.96% 45.00% 20.37% -29.90%
1 Week -2.47% -2.33% 45.00% 21.37% -30.88%
2 Weeks -2.31% -5.75% 40.00% 39.70% -30.39%
1 Month -2.81% -7.83% 36.84% 46.27% -30.39%

Seasonality & Day-of-Week Patterns

Monthly Seasonality

Insufficient historical data for monthly seasonality analysis (requires 7+ years of data).

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.36% 38.3% 227
Tuesday 0.11% 44.3% 253
Wednesday 0.03% 47.0% 251
Thursday -0.27% 47.1% 244
Friday -0.18% 47.4% 247

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 68.0%

Insider Transactions — Smart Summary

Total insider ownership: 1.4%

12-Month Insider Activity Summary

Total Filings6
Net Value+$167,415
Net Shares Change344,316
% of Float0.4%
C-Suite Filings2
Clusters Detected1

Key Insiders

NameTitleNet ValueFilingsActivity
Erck Stanley C +$137,220 1 1 buy
DOUGLAS RICHARD +$111,040 1 1 buy
Masoud Maher President and CEO +$102,915 1 1 buy
Swirsky Douglas J CHIEF FINANCIAL OFFICER +$64,500 1 1 buy
Brooke William W +$64,500 1 1 buy
Hemrajani Rekha -$22,377.638 1 N/A

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2025-08-13 – 2025-08-27 6 6 +$457,797.362 2 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2025-08-13 Swirsky Douglas J CHIEF FINANCIAL OFFICER +$64,500 Transaction at $1.29, now -10.1%
2025-08-13 Masoud Maher President and CEO +$102,915 Transaction at $1.37, now -15.5%
2025-08-13 Erck Stanley C +$137,220 Transaction at $1.37, now -15.5%
2025-08-13 DOUGLAS RICHARD +$111,040 Transaction at $1.39, now -16.4%
2025-08-13 Brooke William W +$64,500 Transaction at $1.29, now -10.1%
2025-08-27 Hemrajani Rekha -$22,377.638 Transaction at $2.09, now -44.6%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for MaxCyte Inc (MXCT) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for MXCT on Trend Edge →